2′-Deoxy-4′-C-ethynyl-2-fluoroadenosine

293.25

293.25

QPQ082R25D

119.31000

-0.22710

1.72±0.1 g/cm3

220.0-221.4 °C (decomp)

669.2±65.0 °C(Predicted)

13.11±0.60

Treatment of human immunodeficiency virus (HIV-1) infection

Agents used to treat RETROVIRIDAE INFECTIONS. (See all compounds classified as Anti-Retroviral Agents.)|Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)|Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)|Compounds that inhibit cell production of DNA or RNA. (See all compounds classified as Nucleic Acid Synthesis Inhibitors.)|Inhibitors of reverse transcriptase (RNA-DIRECTED DNA POLYMERASE), an enzyme that synthesizes DNA on an RNA template. (See all compounds classified as Reverse Transcriptase Inhibitors.)

2'-deoxy-4'-ethynyl-2-fluoroadenosine

Human Drugs -> EU pediatric investigation plans